Middle East Healthcare Company

Middle East Healthcare Company

TTADAWUL:4009
23.90
SAR
-0.84
(-3.40%)
1.54EPS
21.28P/E
2.93BMarket Cap
Oct 29Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
16.67
17.55
15.88
15.11
16.26
19.02
20.35
23.38
28.83
31.32
33.71
34.57
Basic EPS, GAAP
4.24
3.94
3.47
1.87
1.06
0.89
0.19
0.82
0.19
3.06
3.28
1.5
Free Cash Flow per Basic Share
0.86
1.22
1.22
-2.14
-4.06
-5.69
-3.7
-1.89
-0.45
3.11
0.95
3.09
Dividend per Share
1.8
2
2
2
- -
- -
- -
- -
- -
- -
0.5
- -
Book Value per Share
15.26
16.73
18.52
15.71
12.86
13.38
13.66
14.44
14.34
17.67
20.34
16.76
Tangible Book Value per Share
15.22
16.69
18.45
15.65
12.81
13.31
13.58
14.35
14
17.19
19.72
16.08
Basic Weighted Avg Shares
92
92
92
92
92
92
92
92
92
92
92
92
Sales/Revenue/Turnover
1,535
1,616
1,462
1,391
1,497
1,751
1,873
2,152
2,653
2,883
3,103
3,189
Operating Margin (%)
25.7
22.25
20.16
11.82
7.03
6.42
3.34
6.73
12.48
15.49
12.67
10.76
Depreciation Expense
52
64
77
89
98
127
141
146
190
217
246
259
Net Income, GAAP
390
363
319
172
98
82
17
75
17
282
302
138
Effective Tax Rate (%)
- -
1.09
1.84
3.57
5.43
6.82
39
11.84
89.27
8.47
4.92
9.98
Profit Margin (%)
25.43
22.45
21.85
12.39
6.52
4.68
0.92
3.49
0.64
9.78
9.73
4.33
Working Capital
674
592
606
512
201
306
209
326
401
911
800
828
LT Debt
56
129
131
330
671
870
1,056
1,238
1,356
1,813
1,700
1,692
Total Equity
1,466
1,599
1,756
1,491
1,223
1,275
1,295
1,372
1,365
1,674
1,928
1,600
Return on Invested Capital (%)
- -
21.65
15.49
8.36
4.85
4.16
1.12
3.65
0.92
10.01
8.61
7.9
Return on Capital (%)
- -
21.45
18.03
9.11
5.68
4.64
1.58
4.06
0.8
12.06
11.09
6.99
Return on Common Equity (%)
- -
24.63
19.7
10.94
7.42
6.79
1.38
5.81
1.29
19.15
17.26
8.26

Capital Structure

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
843
784
790
LT Borrowings
1,587
1,559
1,577
LT Finance Leases
113
118
115
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
92
92
92
Market Capitalization
2,997
3,192
2,932

Working Capital

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,256
2,168
2,335
Cash, Cash Equivalents & STI
26
24
83
Accounts Receivable, Net
2,016
1,914
2,001
Inventories
65
83
103
Total Current Liabilities
1,457
1,468
1,507
Payables & Accruals
- -
- -
- -
ST Debt
843
784
790
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.49%
8.96%
15.15%
Free Cash Flow
-112.92%
-204.83%
-69.54%
Net Income, GAAP
161.85%
348.57%
7.05%
Sales/Revenue/Turnover
7.7%
12.29%
7.62%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
689
713
732
749
2,883
2025
734
791
769
809
3,103
2026
765
846
- -
- -
- -

Quarterly Earnings Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.48
0.68
0.69
1.16
3.06
2025
1.74
0.22
0.44
0.41
3.28
2026
0.28
0.37
- -
- -
- -

Quarterly Dividends Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.5
2026
- -
- -
- -
- -
- -

Company Description

CEO
Nezar Mohammed Sultan Bahabri
Full Time Employees
4,322
Sector
Health services
Industry
Medical/Nursing services
Address
4, Batterjee Road Jeddah MC Saudi Arabia 21461
IPO Date
Mar 29, 2016
Business
Middle East Healthcare Company (4009.SR), also known as Saudi German Health, operates a network of multi-specialty tertiary care hospitals, clinics, medical education facilities, rehabilitation and physiotherapy centers, laboratories, radiology centers, and pharmacies across the Middle East and North Africa. The company provides comprehensive inpatient and outpatient services, including anesthesiology, anorectal laser clinics, audiology, cardiac care, chest clinics, chiropractic care, dental centers, emergency departments, gastroenterology, ophthalmology, oral and maxillofacial surgery, pediatric intensive care, and pharmacy sales; it manages key facilities such as Saudi German Hospital Jeddah (218 beds), Saudi German Hospital-Aseer (400 beds), Saudi German Hospital-Riyadh (300 beds), Saudi German Hospital-Madinah (300 beds), Saudi German Hospital-Hail (150 beds), Saudi German Hospital-Dammam (150-300 beds), Saudi German Hospital-Sanaa (300 beds), Saudi German Hospital-Dubai (300 beds), and Saudi German Hospital-Sharjah, along with standalone clinics like Beverly Clinics and operations in Egypt, Morocco, and Pakistan. Founded in 1988 by brothers Eng. Sobhi Batterjee and Dr. Khalid Batterjee and headquartered in Jeddah, Saudi Arabia, the group serves approximately 2.5 million patients annually through over 8,500 healthcare professionals, with a focus on advanced treatments via partnerships with German, US, UK, and Canadian providers, including Mayo Clinic Care Network affiliations for its Cairo and Riyadh hospitals. Recent developments include a 2020 rebranding from Saudi German Hospitals Group to Saudi German Health to consolidate its expanded ecosystem of hospitals, clinics, pharmacies, and education under one brand; launches of new facilities such as Saudi German Hospital Dammam and Ajman in 2019, clinics in Abha and a branch in Makkah in 2022, and Al Jami`ah District branch in Jeddah in 2021; a November 2025 board resolution to repurchase sukuk with ongoing updates; and a November 2025 fine for securities listing rules violation, alongside sustained revenue growth to SAR 3.04 billion (TTM) driven by segment expansion in Saudi Arabia, UAE, Yemen, and beyond.[][][]